Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study

BACKGROUND AND PURPOSE: Synthetic cannabinoids (often sold as Spice or K2) have become a very popular alternative to cannabis due to their easy access and portrayed safety. Controlled studies on the behavioural effects of synthetic cannabinoids are currently lacking, which hampers risk assessments o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Pharmacol
Autors principals: Theunissen, Eef L, Hutten, Nadia R P W, Mason, Natasha L, Toennes, Stefan W, Kuypers, Kim P C, de Sousa Fernandes Perna, Eliza B, Ramaekers, Johannes G
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Research Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740243/
https://ncbi.nlm.nih.gov/pubmed/29164599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14066
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars